Cell Reports (Oct 2023)

Myeloid BAF60a deficiency alters metabolic homeostasis and exacerbates atherosclerosis

  • Yang Zhao,
  • Yuhao Liu,
  • Guizhen Zhao,
  • Haocheng Lu,
  • Yaozhong Liu,
  • Chao Xue,
  • Ziyi Chang,
  • Hongyu Liu,
  • Yongjie Deng,
  • Wenying Liang,
  • Huilun Wang,
  • Oren Rom,
  • Minerva T. Garcia-Barrio,
  • Tianqing Zhu,
  • Yanhong Guo,
  • Lin Chang,
  • Jiandie Lin,
  • Y. Eugene Chen,
  • Jifeng Zhang

Journal volume & issue
Vol. 42, no. 10
p. 113171

Abstract

Read online

Summary: Atherosclerosis, a leading health concern, stems from the dynamic involvement of immune cells in vascular plaques. Despite its significance, the interplay between chromatin remodeling and transcriptional regulation in plaque macrophages is understudied. We discovered the reduced expression of Baf60a, a component of the switch/sucrose non-fermentable (SWI/SNF) chromatin remodeling complex, in macrophages from advanced plaques. Myeloid-specific Baf60a deletion compromised mitochondrial integrity and heightened adhesion, apoptosis, and plaque development. BAF60a preserves mitochondrial energy homeostasis under pro-atherogenic stimuli by retaining nuclear respiratory factor 1 (NRF1) accessibility at critical genes. Overexpression of BAF60a rescued mitochondrial dysfunction in an NRF1-dependent manner. This study illuminates the BAF60a-NRF1 axis as a mitochondrial function modulator in atherosclerosis, proposing the rejuvenation of perturbed chromatin remodeling machinery as a potential therapeutic target.

Keywords